MYO1G and neoplasm: MYO1G gene expression was significantly and positively correlated with the expression of immune checkpoint genes (Figure 4C, P < 0.001), suggesting that MYO1G promoter methylation regulated gene expression and subsequently impacted anti-tumor immune response.